TipRanks
Panbela Therapeutics (PBLA)
OTHER OTC:PBLA
US Market
PBLA
Panbela Therapeutics
RESEARCH TOOLSreports
Want to see PBLA full AI Analyst Report?

Panbela Therapeutics (PBLA) Income Statement

246 Followers

Panbela Therapeutics Income Statement

Last quarter (Q3 2024), Panbela Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Panbela Therapeutics's net income was $-7.17M. See Panbela Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -25.65M$ -35.73M$ -10.01M$ -5.75M$ -4.32M
Operating Expenses
$ 25.65M$ 34.09M$ 10.01M$ 5.75M$ 4.32M
Depreciation and Amortization
$ 0.00$ 16.36K$ 10.01K$ 114.00K$ 4.32K
EBITDA
$ -25.77M$ -34.74M$ -10.61M$ -4.93M$ -4.42M
Operating Income
$ -51.29M$ -34.09M$ -10.01M$ -5.75M$ -4.32M
Other Income/Expenses
$ 25.84M$ -956.00K$ -613.00K$ 691.00K$ -2.29M
Pretax Income
$ -25.45M$ -35.05M$ -10.62M$ -5.06M$ -6.62M
Net Income
$ -25.26M$ -34.93M$ -10.13M$ -4.77M$ -6.20M
Per Share Metrics
Basic EPS
$ -232.43K$ -40.75K$ -20.77K$ -14.80K$ -26.10K
Diluted EPS
$ -232.43K$ -40.75K$ -20.77K$ -14.80K$ -26.10K
Weighted Average Shares Outstanding
 3.13M 857.00 488.00 322.00 238.00
Weighted Average Shares Outstanding (Diluted)
 3.13M 857.00 488.00 322.00 238.00
Currency in USD

Panbela Therapeutics Earnings and Revenue History